N-Acetyl Cysteine (NAC)
N-Acetyl Cysteine (NAC) is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis
Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
The FIGHT-RP1 Study
Clinical Trials (9)
The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis
Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
The FIGHT-RP1 Study
N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
NAC Trial for Anosmia
Treatment Resistant Epilepsy and N-Acetyl Cysteine
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9